Annovis Bio stockholders elect directors, approve equity plan amendment, ratify auditors at annual meeting

Annovis Bio, Inc.

All five director nominees elected; Michael Hoffman (3,856,586 for), Maria Maccecchini (3,888,261 for), Claudine Bruck, Reid McCarthy, Mark White.
Amendment to 2019 Equity Incentive Plan approved, adding 1,000,000 shares to the share reserve.
Ratification of Ernst & Young as independent auditor for FY2024 approved (7,214,275 for, 48,270 against).
66.10% of outstanding shares (7,278,396 shares) were represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.